Cardiorenal syndrome, a literature review
Keywords:
Renal Insufficiency, Chronic, Cardiovascular Diseases, Cardio-Renal Syndrome, Cardiovascular Physiological PhenomenaAbstract
Introduction: globally there is an increase in the rates of heart disease, kidney disease and the concomitant presence of both; with a notorious presence of the cardio-renal syndrome.
Aim: To describe the types of cardio-renal syndrome, according to their physiopathology.
Methods: a bibliographic review was conducted, using the PubMed, SciELO, Ebsco and Clinical Key databases. The period in which the information was searched was June 10-15, 2020. The search strategies included: chronic renal disease, cardiovascular diseases, cardiac and renal syndrome, physiopathological mechanisms; and their translation into Spanish.
Development: Cardio-renal syndrome is a highly active biomedical research field. The great utility of the identification of cardiovascular or renal damage justifies the wide dispersion in the literature on this topic. New strategies are been defined in populations at risk for early diagnosis, reducing morbidity and mortality.
Conclusions: the 5 types of the cardio-renal syndrome were described. The physiopathology of each one indicates that the renal and cardiovascular systems imbricate common physiopathological mechanisms responsible for the posterior damage of the non-affected organ.
Downloads
References
1. Tejero Hernández AM, García Martínez E, Arroyo Marin MJ, Gómez Guzmán E. Tolvaptán en un caso de síndrome cardiorrenal pediátrico. ¿Cuál es su papel? Arch Argent Pediatr [Internet]. 2018 [citado 13 de junio 2020];116(2):279-282. Disponible en: https://www.sap.org.ar/docs/publicaciones/archivosarg/2018/v116n2a24.pdf
2. Carubelli V, Lombardi C, Gorga E, Ravera A, Metra M, Mentz RJ. Cardiorenal Interactions. Heart Failure Clin [Internet]. 2016 [citado 13 de junio 2020];12:335–347. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27371511/
3. Takahashi A, Takase H, Toriyama T, Sugiura T, Kurita Y, Ueda R, et al. Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis--a randomized study. Nephrol Dial Transplant [Internet]. 2006 [citado 13 de junio 2020];21(9). Disponible en: https://pubmed.ncbi.nlm.nih.gov/16766543/
4. Castellanos Castillo Y, Fong Estrada J, Vázquez Trigo JM, Oliva Fong J. Marcadores de daño renal en pacientes con factores de riesgo de enfermedad renal crónica. MEDISAN [Internet]. 2018 [citado 13 de junio 2020]; 22(2): 142-148. Disponible en: http://www.medisan.sld.cu/index.php/san/article/ view/1945
5. Ministerio de Salud Pública. Dirección Nacional de Registros Médicos y Estadísticas de Salud. Anuario estadístico de la Salud, 2018 [Internet]. La Habana: Ministerio de Salud Pública; 2019 [citado 13 de junio 2020]. Disponible en: http://files.sld.cu/bvscuba/files/2019/04/Anuario-Electr%C3%B3nico-Espa%C3%B1ol-2018-ed-2019-compressed.pdf
6. Naranjo M, Lerma EV, Rangaswami J. Cardio-Renal Syndrome: A double edged sword. Disease-a-Month [Internet]. 2017 [citado 13 de junio 2020];63:92–100. Disponible en: https://www.sciencedirect.com/journal/disease-a-month/vol/63/issue/4
7. McCullough PA, Soman S. Cardiorenal Syndrome: A Call to Action for a Pressing Medical Issue. Adv Chronic Kidney Dis [Internet]. 2018 [citado 13 de junio 2020];25(5):379-381. Disponible en: https://scholarlycommons.henryford.com/nephrology_articles/11/
8. Pereira Rodríguez JE, Boada Morales L, Niño Serrato DR, Caballero Chavarro M. Síndrome cardiorrenal. Rev Colomb Cardiol [Internet]. 2017 [citado 13 de junio 2020];24(6):602-613. Disponible en: http://www.scielo.org.co/pdf/rcca/v24n6/0120-5633-rcca-24-06-00602.pdf
9. Chitturi C, Novak JE. Diuretics in the Management of Cardiorenal Syndrome. Adv Chronic Kidney Dis [Internet]. 2018 [citado 13 de junio 2020];25(5):425-433. Disponible en: https://www.ackdjournal.org/article/S1548-5595(18)30142-3/abstract
10. Thierer J. Síndrome cardiorrenal. Una revisión. Rev Urug Cardiol [Internet]. 2018 [citado 13 de junio 2020];33:8-27. Disponible en: http://www.scielo.edu.uy/pdf/ruc/v33n1/1688-0420-ruc-33-01-81.pdf
11. Dávila Mora S, Zea Dávila E, Nani Silva E, Tinoco Mesquita E. Síndrome cardio-renal tipo 1. Mecanismos fisiopatológicos y papel de los nuevos biomarcadores. Insuf Card [Internet]. 2016 [citado 13 de junio 2020];11(1):31-38. Disponible en: http://www.insuficienciacardiaca.org/html/v11n1/body/v11n1a06.html
12. Núñez J, Miñana G, Santas E, Bertomeu González V. Síndrome cardiorrenal en la insuficiencia cardiaca aguda: revisando paradigmas. Rev Esp Cardiol [Internet]. 2015 [citado 13 de junio 2020];68(5):426–435. Disponible en https://www.revespcardiol.org/es-sindrome-cardiorrenal-insuficiencia-cardiaca-aguda-articulo-S0300893215000123
13. Ronco C, Di Lullo L. Cardiorenal Syndrome. Heart Failure Clin [Internet]. 2014 [citado 13 de junio 2020];10:251–280. Disponible en: https://www.heartfailure.theclinics.com/article/S1551-7136(13)00160-8/abstract
14. Graziani G, Pini D, Oldani S, Cucchiari D, Podesta MA, Badalamenti S. Renal dysfunction in acute congestive heart failure a common problem for cardiologists and nephrologists. Heart Fail Rev [Internet]. 2014 [citado 13 de junio 2020];19(6): 699-708. Disponible en: https://pubmed.ncbi.nlm.nih.gov/24297366/
15. Tabucanon T, Hong W, Tang W. Right heart failure and cardiorenal syndrome. Cardiol Clin [Internet]. 2020 [citado 13 de junio 2020];38:185-202. Disponible en: https://www.cardiology.theclinics.com/article/S0733-8651(20)30004-7/abstract
16. Felker G, Ellison D, Mullens W, Cox Z, Testani J. Diuretic therapy for patients with heart failure. Journal of the American College of Cardiology [Internet]. 2020 [citado 13 de junio 2020];75(10). 1178-1195. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32164892/
17. Salim A, Ghali Benouna ME, Mourid ME, Habbal R. Síndrome Cardiorrenal Tipo 2: Um Forte Fator Prognóstico da Sobrevida. Int J Cardiovasc Sci [Internet]. 2017 [citado 13 de junio 2020];30(5):425-432. Disponible en: https://www.scielo.br/scielo.php?pid=S2359-56472017000500425&script =sci_arttext&tlng=pt
18. Preza PM, Hurtado A, Armas V, Cárcamo CP. Síndrome cardiorenal tipo 1 en la unidad de cuidados intensivos coronarios del Hospital Nacional Arzobispo Loayza. Arch Cardiol Mex. [Internet]. 2015 [citado 13 de junio 2020];85(3):176-187. Disponible en: http://archivoscardiologia.com/previos/(2015)%20ACM%20Vol%2085.%203%20JULIO-SEPTIEMBRE/ACMX_2015_85_3_176-187.pdf
19. Constantin I, Varela CF, del Castillo SI, Romeo F, Guzzetti E, Citterio PI, et al. Cistatina C como predictor de síndrome cardiorrenal y mal pronóstico en pacientes internados por insuficiencia cardíaca aguda y función renal normal. Rev Argent Cardiol [Internet]. 2016 [citado 13 de junio 2020];84:15-20. Disponible en: https://www.sac.org.ar/wp-content/uploads/2016/03/v84n1a5-es.pdf
20. Garcia Blas F, Bonanad C, Llácer P, Ventura S, Núñez JM, Sánchez R, et al. Estrategias diuréticas en insuficiencia cardiaca aguda con disfunción renal: terapia convencional frente a guiada por el antígeno carbohidrato 125. Diseño de ensayo clínico. Rev Esp Cardiol [Internet]. 2017 [citado 13 de junio 2020];70(12):1067-1073. Disponible en: https://www.revespcardiol.org/es-estrategias-diureticas-insuficiencia-cardiaca-aguda-articulo-S0300893217301239
21. Boceta-Osuna J, Salgueira-Lazo M . Paciente con síndrome cardiorenal terminal que no acepta una limitación de esfuerzo terapéutico. Análisis del problema ético-clínico. Medicina Paliativa [Internet]. 2019 [citado 13 de junio 2020];26(3):126-129. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1134248X13000906
22. Ronco C, Bellasi A, di Lullo L. Cardiorenal Syndrome: An Overview. Adv Chronic Kidney Dis [Internet]. 2018 [citado 13 de junio 2020];25(5):382-390. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30309455/
23. di Lullo L, Bellasi A, Russo D, Cozzolino M, Ronco. Cardiorenal acute kidney injury: Epidemiology, presentation, causes, pathophysiology and treatment. International Journal of Cardiology [Internet]. 2017 [citado 13 de junio 2020];227:143–150. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27863290/
24. Meza Ayala CM, Dehesa López E. Factores asociados con lesión renal aguda en pacientes hospitalizados con diagnóstico de insuficiencia cardiaca agudizada. Med Int Méx [Internet]. 2018 [citado 13 de junio 2020];34(1):19-28. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=77358
25. Rubinstein J, Sanford D. Treatment of Cardiorenal Syndrome. Cardiol Clin [Internet]. 2019 [citado 13 de junio 2020];37:267–273. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31279420/
26. Granata A, Clementi A, Virzì GM, Brocca A, de Cal M. Cardiorenal syndrome type 4: From chronic kidney disease to cardiovascular impairment. European Journal of Internal Medicine [Internet]. 2016 [citado 13 de junio 2020];30:1–6. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26961461/
27. Pinheiro da Silva AL, Vaz da Silva MJ. Type 4 cardiorenal syndrome. Rev Port Cardiol [Internet]. 2016 [citado 13 de junio 2020];35(11):601-616. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27712930/
28. Suresh H, Arun BS, Moger V, Swamy M. Cardiorenal syndrome type 4: A study of cardiovascular diseases in chronic kidney disease. Indian Heart Journal [Internet]. 2017 [citado 13 de junio 2020];69:11–16. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319008/
29. Latini R, Aleksova A, Masson S. Novel biomarkers and therapies in cardiorenal syndrome. Current Opinion in Pharmacology. [Internet]. 2016 [citado 13 de junio 2020];27:56-61. Disponible en: https://europepmc.org/article/med/26894469
30. Chávez López EL, Alemán Ortiz OF, Nando Villicaña CC, Rosas Munive E. Síndrome cardiorrenal: Nuevas perspectivas. Rev Mex Cardiol [Internet]. 2015 [citado 13 de junio 2020];26(1):39-52 Disponible en: https://www.medigraphic.com/pdfs/cardio/h-2015/h151f.pdf
31. Yancy C, Drazner M, Coffin S, Cornwell W, Desai S, Erwin J, et al. 2020 ACC/HFSA/ISHLT Lifelong learning statement for advanced heart failure and transplant cardiology specialists. Journal of Cardiac Failure [Internet]. 2020 [citado 13 de junio 2020];26(3):254-269. Disponible en: https://hfsa.org/sites/default/files/2020-04/PIIS1071916420300543.pdf
32. Jentzer JC, Lakhmir S, Chawla MD. A clinical approach to the acute cardiorenal syndrome. Crit Care Clin [Internet]. 2015 [citado 13 de junio 2020];31:685-703. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26410138/
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: authors retain their copyright and grant the journal the right of first publication of their work, which is simultaneously subject to the Creative Commons Attribution-NonCommercial 4.0 International License that allows third parties to share the work as long as the author and first publication in this journal are indicated, for non-commercial use. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional telematic archive or publishing it in a monographic volume) as long as the initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work via the Internet (e.g., in institutional telematic archives, in their web page or in Pre-print servers) before and during the submission process, which can lead to interesting exchanges and increase citations of the published work. (See The Open Access Effect).
